GEMMABio raises $34m to advance gene therapy programmes
US-based gene therapy startup, GEMMABio has raised $34m in seed funding to help advance its portfolio of gene therapy programmes. …
All articles by Jenna Philpott
Jenna Philpott
Jenna Philpott is a healthcare and pharmaceutical reporter. Coming from a scientific background, Jenna has expertise in biochemistry, genetics and cancer science. Jenna previously wrote freelance articles focused on oncology and healthcare.
-
-
Novo gets the green light for once-daily haemophilia drug following setbacks
Novo Nordisk has secured approval from the US Food and Drug Administration (FDA) for Alhemo (concizumab-mtci) as a once-daily treatment…
-
FDA approves Lilly’s obesity med Zepbound to treat obstructive sleep apnoea
Eli Lilly’s blockbuster obesity drug, Zepbound (tirzepatide), has secured a label expansion from the US Food and Drug Administration (FDA)…
-
Vertex secures two FDA wins for cystic fibrosis, both with boxed warnings
Vertex Pharmaceuticals has secured two simultaneous US Food and Drug Administration (FDA) approvals for cystic fibrosis (CF) treatments, but both…
-
Novartis and Olema expand alliance with $250m to boost breast cancer trials
Olema Oncology has announced another clinical trial collaboration and supply agreement with Novartis for a Phase III trial in metastatic…
-
Faron Pharma secures UK innovation passport for blood cancer immunotherapy
Faron Pharmaceuticals is advancing its cancer immunotherapy programme in the UK, with the region’s regulatory authorities approving the advancement of…
-
CHMP recommends oral peanut allergy immunotherapy treatment for toddlers
The European Medicines Agency’s (EMAs) Committee for Medicinal Products for Human Use (CHMP) has recommended extending the use of Stallergenes…
-
UK Government to launch first ever men’s health strategy
As Men’s Health Awareness Month comes to an end, UK Health Secretary Wes Streeting has announced the development of a…
-
UK reports near eradication of meningitis C amid declining vaccine uptake
New data from the UK Health Security Agency (UKHSA) indicates significant progress in combating meningitis caused by meningococcal group C…
-
Advanz Pharma’s liver disease drug pulled from European market after court hearing
Advanz Pharma’s liver disease drug Ocaliva (obeticholic acid) will no longer be available in Europe after the General Court of…